AJP - Regu Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 250: R1014-R1020, 1986;
0363-6119/86 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujita, T.
Right arrow Articles by Sato, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujita, T.
Right arrow Articles by Sato, Y.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 250, Issue 6 1014-R1020, Copyright © 1986 by American Physiological Society


ARTICLES

Changes in blood pressure and extracellular fluid with taurine in DOCA-salt rats

T. Fujita and Y. Sato

The effect of taurine, a sulfur amino acid, on blood pressure and extracellular fluid volume in deoxycorticosterone acetate (DOCA)-salt hypertensive rats was studied. Uninephrectomized rats showed average systolic pressure of 175 +/- 3 mmHg after the 28 days of treatment with DOCA while receiving 1% NaCl solution to drink. The supplementation of 1 and 3% taurine could prevent the development of DOCA-salt hypertension in a dose-related fashion: average pressures on day 28 after these dosages were 126 +/- 2 and 104 +/- 2 mmHg, respectively. Exchangeable body sodium (sodium "space") at week 4 was significantly increased in DOCA-salt rats compared with that of the vehicle-injected control rats. Furthermore, the taurine supplement increased sodium space significantly in the DOCA-salt rats. Overall, there was a negative correlation between the systolic blood pressure and sodium space at week 4 in the taurine-supplemented DOCA-salt rats (r = -0.492, P less than 0.02), although there was a positive correlation between systolic pressure and sodium space in the DOCA-salt rats and the vehicle-injected control rats (r = 0.036, P less than 0.001). The results suggest that taurine loading may attenuate the rise in blood pressure associated with fluid retention during the DOCA-salt treatment and that the fall in blood pressure with its consequence for the renal circulation may be the cause of fluid retention.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online